• Blog
  • Clinical Microbiology Market Analysis & Forecast

    Clinical Microbiology Market Analysis & Forecast

    Clinical Microbiology Market Analysis & Forecast
    Report code - SRHL111 Delivery - 2 Weeks
    Get Free Sample |
    Clinical Microbiology Market Size, Share, Forecast, Industry and Growth Analysis (2022-202 See more...

    Market Insights

    The Clinical Microbiology Market was estimated to grow from USD 3.96 Billion in 2021 to USD 6.18 Billion by 2028 at a CAGR of 6.52% during the forecast period of 2022-2028.

    Clinical Microbiology Market Size

    Wish to Get a Free Sample? Register Here

    What is Clinical Microbiology?

    Clinical microbiology is a branch of medical science which focuses on the isolation and characterization of infectious organisms, in order to manage and treat them in patients. This subject of microbiology is concerned with the prevention, diagnosis, and treatment of infectious diseases.

    Clinical Microbiology Market Features

    Market Size in 2021

    US$ 3.96 Billion

    Market Size in 2028

    US$ 6.18 Billion

    Market Growth by 2022-2028

    CAGR of 6.52%

    Base Year of Study

    2021

    Trend Period

    2017-2020

    Forecast Period

    2022-2028

    Dominant Region

    North America is expected to be the leading region in the market.

    Segments Covered

    By Product Type (Instruments [Laboratory Instruments and Microbiology Analyzers] and Reagents [Pathogen-specific Kits and General Reagents])

    By Disease Type (Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections, Periodontal Diseases, and Other Diseases)

    By End-User Type (Hospitals & Diagnostic Centers, Custom Lab Service Providers, and Academic & Research Institutes)

    By Region (North America, Europe, Asia-Pacific, and Rest of the World)

    Market Drivers

    The prime factors that are driving the Clinical Microbiology market are –

    • Technological advancements.
    • Rising incidence of infectious diseases and pandemic outbreaks (such as COVID-19).
    • Increased funding and public-private partnerships.

    Clinical Microbiology Market Snapshot

    Want to have a closer look at this report. Register Here

    Key Players

    Some of the major players in the market are-

    Segments Analysis

    Product Trends

    The Instruments Product type segment is expected to account for the larger share of the market during the forecast period of 2022-28.

    The market is segmented as instruments and reagents. This segment is driving the market due to technological advancements in molecular techniques and the proteomics field, as well as the widespread adoption of conventional laboratory instruments among researchers and academia.

    End-User Trends

    The Hospitals & Diagnostic Centers segment is expected to hold the largest share of the market during the forecast period of 2022-28.

    The market is segmented as hospitals & diagnostic centers, custom lab service providers, and academic & research institutes. This segment is driving the market due to the growing awareness among doctors about the benefits offered by molecular diagnostics products, ongoing expansion of healthcare infrastructures across emerging economies, rising incidence of diseases such as HIV-AIDS, malaria, tuberculosis, and epidemic diseases, and the availability of technologically advanced products for the diagnosis of infectious diseases.

    Regional Analysis

    North America is expected to be the leading region in the market over the forecast period of 2022-28.

    This segment is driving the market due to high adoption of advanced diagnostic technologies, favorable government regulations, and the presence of well-established distribution channels for clinical microbiology product manufacturers and suppliers, all of which are fueling the regional market growth. Europe and Asia-Pacific are also expected to offer substantial growth opportunities during the forecast period.

    Clinical Microbiology Market Region

    Know which region offers the best growth opportunities, Click Here.

    The market is segmented into the following categories. 

    By Product Type

    • Instruments
      • Regional Analysis: North America, Europe, Asia-Pacific, and RoW
      • Type Analysis: Laboratory Instruments and Microbiology Analyzers
    • Reagents  
      • Regional Analysis: North America, Europe, Asia-Pacific, and RoW
      • Type Analysis: Pathogen-specific Kits and General Reagents

    By Disease Type

    • Respiratory Diseases
    • Bloodstream Infections
    • Gastrointestinal Diseases
    • Sexually Transmitted Diseases
    • Urinary Tract Infections
    • Periodontal Diseases
    • Other Diseases

    By End-User Type

    • Hospitals & Diagnostic
    • Custom Lab Service
    • Academic & Research Institutes

    By Region

    • North America (Country Analysis: the USA, Canada, and Mexico) 
    • Europe (Country Analysis: Germany, France, the UK, Russia, Spain, and Rest of Europe)
    • Asia-Pacific (Country Analysis: China, Japan, India, South Korea, and Rest of Asia-Pacific)
    • Rest of the World (Sub-Region Analysis: Latin America, the Middle East, and Others)

    Report Features

    This report provides market intelligence most comprehensively. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

    Report – Features

    Market Segmentation

    04

    Regions Covered

    04

    Countries/Sub-Regions Covered

    17

    No. of Figures & Tables

    >120

    Company Profiles

    10

     

    The following are the key features of the report:

    • Overview, industry life cycle analysis, supply chain analysis
    • Environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
    • Trend and forecast analysis.
    • Segment trend and forecast.
    • Competitive landscape and dynamics: Market share, product portfolio, Technology launches, etc.
    • Attractive segments and associated growth opportunities
    • Emerging trends
    • Strategic growth opportunities for the existing and new players
    • Key success factors

    Research Methodology

    This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. 

    More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data. 

    We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.

    Target Audience

    The following is a list of the customers that the market aims to convert the most:

    • Manufacturers
    • Suppliers
    • Distributors
    • Organizations
    • Government bodies

    Customization Option

    Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to 3 players)
    • SWOT analysis of key players (up to 3 players)

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances

    Custom Research: 

    Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    Clinical microbiology is a branch of medical science which focuses on the isolation and characterization of infectious organisms, in order to manage and treat them in patients. This subject of microbiology is concerned with the prevention, diagnosis, and treatment of infectious diseases.

    The Clinical Microbiology Market was estimated to grow from USD 3.96 Billion in 2021 to USD 6.18 Billion by 2028.

    The market is expected to grow at a CAGR of 6.52% during the forecast period.

    Some of the major players in the market are- Abbott Laboratories, Agilent Technologies, Inc., Becton Dickinson and Company, Bio-Rad Laboratories, Inc., Bruker Corporation, Danaher Corporation, Hologic, Inc., Neogen Corporation, The 3M Company, The Merck Group.

    North America is expected to be the leading region in the market over the forecast period.

    Some of the key factors driving the growth of the clinical microbiology market are technological advancements, rising incidence of infectious diseases and pandemic outbreaks (such as COVID-19), and increased funding and public-private partnerships.